 |
University of California, San Francisco |  |
About UCSF | |
Search UCSF | |
UCSF Medical Center |
|
 |
|
|||||||||||||||||||||
|
|
||||||||||||||||||||
|
|
UCSF is one of the world’s leading centers for biomedical research. Trainees can draw on the expertise of world-renowned investigators within the Division of Pediatric Hematology/Oncology and in other UCSF departments and research units. Applicants are encouraged to access the Biomedical Sciences Graduate Program website or the UCSF Cancer Center site to explore the breath and depth of this strong institutional commitment to basic and translational investigation in human diseases. Researchers with the Children’s Cancer and Blood Disease program are performing state of the art research in childhood leukemias, brain tumors, and neuroblastomas. Major efforts involve investigating the genetic basis of pediatric malignancies, the development of accurate mouse models of these cancers, the use of novel, biologically targeted agents in preclinical animal models and human patients, and developing innovative clinical interventions and ways of monitoring disease response. The Division is strongly committed to training the next generation of academic physician-investigators. As evidence of this commitment a substantial proportion of our recent trainees have been awarded Mentored Career Development Awards in the K08 and K23 series from the National Cancer Institute to develop their careers as independent investigators. The hematology program participates in a variety of national collaborative
studies that currently address problems of low bone density in thalassemia,
treatment of hepatitis C, and new approaches to the management of painful
crises in sickle cell anemia. The hemophilia program does research into
outcomes of hemophilia and blood product safety, including clinical trials
of new factor concentrates. It is also studying the treatment of refractory
ITP.
|
|||||||||||||||||||
|
|
